Please login to the form below

Not currently logged in
Email:
Password:

ABPI names latest Code breaches

Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded

Bayer Healthcare, Chiesi and Eli Lilly and Company have been named in advertisements for breaches of the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice, while Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare, Chiesi, Eli Lilly were found to have breached Clause 2 of the ABPI Code of Practice - administered by the Prescription Medicines Code of Practice Authority (PMCPA) - bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Meanwhile Bayer Schering Pharma has been reprimanded for failing to include prescribing information.

The breaches will be highlighted in advertisements in the medical, pharmaceutical and nursing press.

The PMCPA May Code of Practice Review (PDF) has further information on the breaches of the Code.

31st May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics